trending Market Intelligence /marketintelligence/en/news-insights/trending/76MO6n60y6hxPn2TduE6aA2 content esgSubNav
In This List

PTC Therapeutics appoints 2 directors

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


PTC Therapeutics appoints 2 directors

PTC Therapeutics Inc. appointed Emma Reeve and Stephanie Okey to its board.

Reeve is the CFO of Constellation Pharmaceuticals Inc., while Okey was recently the senior vice president, head of North America at Genzyme's rare disease unit.

PTC Therapeutics is a biopharmaceutical company focused on developing medicines to treat rare disorders.